Citation Impact
Citing Papers
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
2003 StandoutScience
Guillain-Barré syndrome and Campylobacter jejuni: a serological study.
1984
Virus-Induced Autoimmunity: Potential Role of Viruses in Initiation, Perpetuation, and Progression of T-Cell–Mediated Autoimmune Disease
2001
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis
2013
Ultrastructural effects of Guillain-Barréserum in cultures containing only rat Schwann cells and dorsal root ganglion neurons
1987
Treatment of Advanced Acanthamoeba Keratitis With Deep Lamellar Keratectomy and Conjunctival Flap
2002
Results of a trial of combined propamidine isethionate and neomycin therapy for acanthamoeba keratitis
1999
Molecular identification of a renal urate–anion exchanger that regulates blood urate levels
2002 StandoutNature
Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain–Barré syndrome and chronic inflammatory demyelinating polyneuropathy
2011
The Increasing Importance of Acanthamoeba Infections1
2000
Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy
1996
Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains
1991
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Cloning of a human gene encoding the general transcription initiation factor IIB
1991 Nature
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Microbial differentiation and changes in susceptibility to antimicrobial agents
2000
Acute axonal Guillain‐Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides
1995
High-dose methylprednisolone suppresses experimental allergic neuritis in the Lewis rat
1989
Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies
1995
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization
1997 Standout
Paraproteinemic Neuropathies
2001
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
1990 Standout
Imaging of multiple sclerosis: Role in neurotherapeutics
2005
Guillain-Barré syndrome
2016 Standout
Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis
2000
Shared and Distinct Functions of Type I and Type III Interferons
2019
Guillain–Barré Syndrome
2012 Standout
Purification of tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme
1995 StandoutNobel
Cognitive impairment in multiple sclerosis
2008 Standout
The prevalence of multiple sclerosis in the world: an update
2001
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
2007 StandoutNature
CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients
1999
Association betweenCampylobacterInfection and Guillain‐Barré Syndrome
1997
Antiganglioside antibodies in Guillain-Barre syndrome after a recent cytomegalovirus infection
1999
Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy
1990 Standout
Cytomegalovirus infection and Guillain-Barre syndrome
1996
Multiple sclerosis
2008 Standout
EPIDEMIOLOGY OF MULTIPLE SCLEROSIS
1996
Anti‐LM1 antibodies in the sera of patients with Guillain‐Barré syndrome, Miller Fisher syndrome, and Motor Neuron Disease
2002
Principal components analysis corrects for stratification in genome-wide association studies
2006 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Fruit bats as reservoirs of Ebola virus
2005 StandoutNature
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
2006 StandoutNature
The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain‐Barré syndrome and in other neuroimmunological disorders
1993
Passive Transfer of IgG Anti-GM1 Antibodies Impairs Peripheral Nerve Repair
2010
Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndrome
1996
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
2015
The epidemiology of multiple sclerosis
2016
Pathogenesis of tissue injury in MS lesions
1999
In vitro demyelination by serum antibody from patients with guillain‐barré syndrome requires terminal complement complexes
1991
Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages
2006
N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndrome
1994
The clinical correlates of high‐titer IgG anti‐GM1 antibodies
1994
IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein
1998
Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome
1997
Campylobacter jejuni strains from patients with guillain‐barré syndrome belong mostly to penner serogrpup 19 and contain β‐N‐acetylglucosamine residues
1993
HIV-1 V3 domain variation in brain and spleen of children with AIDS: Tissue-specific evolution within host-determined quasispecies
1991
Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome
1999
Neuromuscular diseases associated with human immunodeficiency virus infection
1988
Monoclonal IgM antibodies to GM1 and asialo‐GM1 in chronic neuropathies cross‐react with Compylobacter jejuni lipopolysaccharides
1994
Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden
1990
Sequence analysis of the Marburg virus nucleoprotein gene: comparison to Ebola virus and other non-segmented negative-strand RNA viruses
1992
Immunopathogenesis and treatment of the guillain‐barré syndrome—part I
1995
Antibodies to gangliosides and galactocerebroside in patients with Guillain–Barré syndrome with preceding Campylobacter jejuni and other identical infections
1998
Serum antibodies to gangliosides in guillain‐barré syndrome
1988
Antibodies to GT1a ganglioside in patients with Guillain–Barré syndrome
1998
Axonal Transection in the Lesions of Multiple Sclerosis
1998 Standout
Role of Infection Due to Campylobacter jejuni in the Initiation of Guillain-Barre Syndrome
1993
Rate of Pregnancy-Related Relapse in Multiple Sclerosis
1998 Standout
Activated T cells of nonneural specificity open the blood‐nerve barrier to circulating antibody
1995
Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders
2015
Erythropoietin Enhances Nerve Repair in Anti-Ganglioside Antibody-Mediated Models of Immune Neuropathy
2011
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
2006 StandoutNature
Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain‐Barré syndrome and controls: Correlation and prognosis
1993
Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II
1994 StandoutNatureNobel
Erythropoietin Ameliorates Rat Experimental Autoimmune Neuritis by Inducing Transforming Growth Factor-Beta in Macrophages
2011
The Inflammasomes
2010 Standout
Multiple Sclerosis
2000 Standout
Synergy between antibody and P2-reactive T cells in experimental allergic neuritis
1995
Epidemiology of Multiple Sclerosis: A Critical Overview
1993
Peripheral neuropathies and anti-glycolipid antibodies
2002
Anti-Ganglioside Antibody-Mediated Activation of RhoA Induces Inhibition of Neurite Outgrowth
2011
Anti‐GM1 IgG antibodies and campylobacter bacteria in Guillain‐Barré syndrome: Evidence of molecular mimicry
1995
Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin
1991
IgG anti-GM1 antibodies from patients with acute motor neuropathy are predominantly of the IgG1 and IgG3 subclasses
1995
Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection
1996
A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis
1992 Standout
Anti‐ganglioside GM1 antibodies in guillain‐barré syndrome and their relationship to Campylobacter jejuni infection
1995
Immune Mechanisms in Inflammatory Polyneuropathya
1988
IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glycoprotein 35–55 induced experimental autoimmune encephalomyelitis
1999
AN2, the mouse homologue of NG2, is a surface antigen on glial precursor cells implicated in control of cell migration
2002
Environmental risk factors in multiple sclerosis aetiology
2004
Antibody of patients with Guillain-Barré syndrome mediates complement-dependent cytolysis of rat Schwann cells: Susceptibility to cytolysis reflects Schwann cell phenotype
1994
Pathogenesis of Guillain–Barré syndrome
1999
The inflammatory reflex
2002 StandoutNature
A possible harmful late effect of methylprednisolone therapy on a time cluster of optic neuritis
1989
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE
2006
Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States
1997 Standout
Biomarkers in multiple sclerosis
2015
Nuclear Import of Influenza Virus RNA Can Be Mediated by Viral Nucleoprotein and Transport Factors Required for Protein Import
1995 StandoutNobel
Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk
2001
Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain–Barré syndrome
2002
Viability of Acanthamoeba after exposure to a multipurpose disinfecting contact lens solution and two hydrogen peroxide systems
2002
Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome
1991
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
2006 Standout
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Humoral factors in peripheral nerve disease
1987
Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent.
1984 StandoutNobel
In vivo demyelination induced by intraneural injection of anti-galactocerebroside serum: a morphologic study.
1979
Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes
2014
Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides
1997
Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain–Barre syndrome
2000
Monospecific anti-GD1b IgG is required to induce rabbit ataxic neuropathy
1999
BENEFICIAL EFFECTS OF PLASMA EXCHANGE IN ACUTE INFLAMMATORY POLYRADICULONEUROPATHY
1984
Presence of Cytomegalovirus in Cerebrospinal Fluid of Patients with Guillain‐Barré Syndrome
2004
Sequence homology within the morbilliviruses
1985
In Situ Detection of Novel Bacterial Endosymbionts of Acanthamoeba spp. Phylogenetically Related to Members of the Order Rickettsiales
1999
Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor
1992 StandoutScience
RNA Polymerase II Initiation Factor Interactions and Transcription Start Site Selection
1994 StandoutScienceNobel
Guillain-Barr� syndrome and chronic inflammatory demyelinating polyneuropathy: Immune mechanisms and update on current therapies
1995
Intrathecal Interferon Reduces Exacerbations of Multiple Sclerosis
1981 Science
Regulation of RNA Synthesis by the Genomic Termini of Vesicular Stomatitis Virus: Identification of Distinct Sequences Essential for Transcription but Not Replication
1999
A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.
1987
Pathology of the Guillain-Barr� syndrome
1981
In vivo demyelinating activity of sera from patients with Guillain‐Barré syndrome
1982
Multiple Sclerosis
2018 Standout
Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis
1998
Assembly and transcription of synthetic vesicular stomatitis virus nucleocapsids
1991
Epidemiologic evidence for multiple sclerosis as an infection
1993
Purification and characterization of yeast RNA polymerase II general initiation factor g
1992 StandoutNobel
A prospective study of acute idiopathic neuropathy. II. Antecedent events.
1988
A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations
2000
CONTROLLED TRIAL OF PLASMA EXCHANGE IN ACUTE INFLAMMATORY POLYRADICULONEUROPATHY
1984
Purification and properties of Saccharomyces cerevisiae RNA polymerase II general initiation factor a
1992 StandoutNobel
Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice
2002 StandoutNobel
A serial study of new MS lesions and the white matter from which they arise
1998
The extracellular matrix geneFrem1is essential for the normal adhesion of the embryonic epidermis
2004 StandoutNobel
Beyond Neurons: Evidence That Immune and Glial Cells Contribute to Pathological Pain States
2002
RNAi-mediated immunity provides strong protection against the negative-strand RNA vesicular stomatitis virus in Drosophila
2010 StandoutNobel
High-dose steroid therapy in Guillain-Barré syndrome
1988
Chronic Stage Multiple Sclerosis Lesions Contain a Relatively Quiescent Population of Oligodendrocyte Precursor Cells
1998
Plaque-associated expression of human herpesvirus 6 in multiple sclerosis.
1995
Modification of the Single Tryptophan Residue of Staphylococcal Nuclease by a New Mild Oxidizing Agent
1970 StandoutNobel
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Discrimination between Clinically Relevant and Nonrelevant Acanthamoeba Strains Isolated from Contact Lens- Wearing Keratitis Patients in Austria
2000
Inflammatory infiltrates in the spinal cord of patients with Guillain-Barr� syndrome
2003
Characterization of neuropathies associated with elevated IgM serum levels
2004
Rapid Evolution of RNA Genomes
1982 StandoutScience
The Berkeleyamides, Amides from the Acid Lake FungusPenicillum rubrum
2008
Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance
1999
The spectrum of antecedent infections in Guillain-Barre syndrome
1998
Sequence Homology Between Certain Viral Proteins and Proteins Related to Encephalomyelitis and Neuritis
1985 StandoutScienceNobel
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis.
1973
Axonal Guillain-Barr� syndrome: Relation to anti-ganglioside antibodies andCampylobacter jejuni infection in Japan
2000
Utilization of ribonucleotides and RNA primers by Tetrahymena telomerase.
1995 StandoutNobel
A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain–Barré Syndrome
1992 Standout
Allergic encephalomyelitis: Cleavage of the C-tryptophyl bond in the encephalitogenic basic protein from bovine myelin
1969
Microwave Treatment of Contact Lens Cases Contaminated With Acanthamoeba
2001
Yeast RNA polymerase II initiation factor e: isolation and identification as the functional counterpart of human transcription factor IIB.
1992 StandoutNobel
Preceding infections, immune factors, and outcome in Guillain–Barre syndrome
2001
Serum anti‐GQ 1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain‐Barre syndrome
1993
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.
1989
Postoperative contrast enhancement in patients with brain tumor
1985
Acanthamoebaspp. as Agents of Disease in Humans
2003 Standout
Inflammatory demyelinating peripheral neuropathies associated with human T‐cell lymphotropic virus type III infection
1987
Reconstitution of transcription with five purified initiation factors and RNA polymerase II from Saccharomyces cerevisiae
1992 StandoutNobel
LAV Revisited: Origins of the Early HIV-1 Isolates from Institut Pasteur
1991 StandoutScienceNobel
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress
2005
Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller fisher syndrome
1994
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
2008
Works of Stuart D. Cook being referenced
Handbook of Multiple Sclerosis
1991
Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study
2012
Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy
1992
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
2011
Beneficial effect of erythropoietin on experimental allergic encephalomyelitis
2004
Multiple sclerosis: Immune mechanism and update on current therapies
1995
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
2010
Erythropoietin: A Potent Inducer of Peripheral Immuno/Inflammatory Modulation in Autoimmune EAE
2008
Effects of Guillain-Barré sera containing antibodies against glycolipids in cultures of rat Schwann cells and sensory neurons
1992
Acanthamoeba Keratitis
1998
Caspase-1 expression in multiple sclerosis plaques and cultured glial cells
2002
250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
2009
Measles virus L protein evidences elements of ancestral RNA polymerase
1988
Detection of latent virus mRNA in tissues using the polymerase chain reaction
1989
Measles Vaccination Does Not Prevent Multiple Sclerosis
1990
Triple‐Dose Versus Single‐Dose Gadoteridol in Multiple Sclerosis Patients
1994
Anti-MAG IgM paraproteins from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide
1992
Cell death and birth in multiple sclerosis brain
1997
Sequence variability and function of measles virus 3′ and 5′ ends and intercistronic regions
1988
Advancing treatment with interferon beta-1b (Betaferon�/Betaseron�) in the next decade
2003
Anti-GM1 IgA antibodies in Guillain-Barré syndrome
1992
Declining incidence of multiple sclerosis in the Orkney Islands
1985
Serum levels of CXCL13 are elevated in active multiple sclerosis
2009
FINE STRUCTURAL ASPECTS OF DEMYELINATION IN VITRO. THE EFFECTS OF GUILLAIN-BARRÉ SERUM
1971
Possible beneficial effect of high‐dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis
1980
The role of autoantibody and immune complexes in the pathogenesis of Guillain-Barre syndrome
1981
Mycoplasma antibody in guillain‐barré syndrome and other neurological disorders
1980
Effect of high–dose intravenous steriod administration on contrast‐enhancing computed tomographic scan lesions in multiple sclerosis
1984
Pattern of cellular and humoral events in experimental allergic encephalomyelitis
1968
Multiple sclerosis and distemper in Iceland 1966-1978
2009
Neutralizing antibodies to canine distemper and measles virus in multiple sclerosis
1979
Role of infection in Guillain-Barr� syndrome: Laboratory confirmation of herpesviruses in 41 cases
1981
Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome
1991
Multiple sclerosis and viruses
1980
Antibodies to sulfated glycolipids in Guillain-Barré syndrome
1991
The ultrastructure of circulating immunocytes in Guillain‐Barre syndrome
1970
Serum 19S and 7S demyelinating antibodies in multiple sclerosis.
1968